Clinical Trial Update: Phase II Study of TS-1 Therapy and TS-1+PSK Therapy Against Advanced Gastric Carcinoma [Phase 2, Phase 3]

View source ↗

Summary

Terminated Phase II/Phase III clinical trial evaluating TS-1 therapy alone and TS-1 plus PSK therapy in advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• PSK (polysaccharide-K)
• TS-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Eastern Network of Cancer Immunological Therapy, Japan | Conditions: Gastric Cancer | Phase 2, Phase 3 | Status: TERMINATED